Loma Therapeutics is a biotech company developing a targeted immunotherapy for HPV-induced cancer. The company was founded in Denmark in August 2023 and is incubating at the BioInnovation Institute. Loma already has strong pre-clinical data from mice, non-human primates (NHPs), and human blood samples that demonstrate immune responses in all subjects, reduced tumor growth, and increased survival compared to other therapies in development.